Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
PUT
Synopsys
SNPS
$78.9B
| $1.68M | ﹤0.01% |
12,100
-600
| -5% | -$82.3K |
|
|
NUAN
3152
CALL
DELISTED
Nuance Communications, Inc.
NUAN
| $1.68M | ﹤0.01% |
94,300
-90,038
| -49% | -$1.49M |
|
3153
CALL
Invesco CurrencyShares Japanese Yen Trust
FXY
$452M
| $1.68M | ﹤0.01% |
19,200
-3,900
| -17% | -$341K |
|
3154
Karyopharm Therapeutics
KPTI
$45.3M
| $1.67M | ﹤0.01% |
5,823
+3,503
| +151% | +$760K |
|
3155
Red Rock Resorts
RRR
$3.6B
| $1.67M | ﹤0.01% |
69,883
-9,533
| -12% | -$212K |
|
|
NTUS
3156
DELISTED
Natus Medical Inc
NTUS
| $1.67M | ﹤0.01% |
50,704
+13,249
| +35% | +$425K |
|
3157
TTEC Holdings
TTEC
$123M
| $1.67M | ﹤0.01% |
42,121
+23,182
| +122% | +$1.02M |
|
3158
Usana Health Sciences
USNA
$275M
| $1.67M | ﹤0.01% |
21,209
-3,451
| -14% | -$254K |
|
3159
PUT
American Electric Power
AEP
$68.7B
| $1.66M | ﹤0.01% |
17,600
+8,000
| +83% | +$739K |
|
3160
ICF International
ICFI
$1.72B
| $1.66M | ﹤0.01% |
18,161
+9,187
| +102% | +$791K |
|
3161
CALL
Qorvo
QRVO
$8.68B
| $1.66M | ﹤0.01% |
14,300
+7,000
| +96% | +$677K |
|
3162
Marten Transport
MRTN
$1.24B
| $1.66M | ﹤0.01% |
115,958
+52,911
| +84% | +$755K |
|
3163
PUT
NovoCure
NVCR
$1.88B
| $1.66M | ﹤0.01% |
19,700
+10,200
| +107% | +$823K |
|
|
ACB
3164
Aurora Cannabis
ACB
$185M
| $1.66M | ﹤0.01% |
6,386
+6,125
| +2,347% | +$2.28M |
|
|
POLY
3165
DELISTED
Plantronics, Inc.
POLY
| $1.65M | ﹤0.01% |
60,450
+29,520
| +95% | +$888K |
|
|
HEES
3166
DELISTED
H&E Equipment Services
HEES
| $1.65M | ﹤0.01% |
49,307
+8,951
| +22% | +$290K |
|
|
TRHC
3167
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.65M | ﹤0.01% |
33,825
+12,630
| +60% | +$591K |
|
|
CRC
3168
PUT
DELISTED
California Resources Corporation
CRC
| $1.64M | ﹤0.01% |
182,000
-50,300
| -22% | -$407K |
|
3169
CALL
Pultegroup
PHM
$25.2B
| $1.64M | ﹤0.01% |
42,300
-16,100
| -28% | -$626K |
|
3170
Webster Financial
WBS
$12.8B
| $1.64M | ﹤0.01% |
30,719
-13,467
| -30% | -$648K |
|
|
AMED
3171
CALL
DELISTED
Amedisys
AMED
| $1.64M | ﹤0.01% |
9,800
-200
| -2% | -$29.7K |
|
3172
Ingles Markets
IMKTA
$1.63B
| $1.64M | ﹤0.01% |
34,460
+23,080
| +203% | +$983K |
|
3173
Nokia
NOK
$52.3B
| $1.63M | ﹤0.01% |
440,063
+369,007
| +519% | +$1.45M |
|
|
S
3174
CALL
DELISTED
Sprint Corporation
S
| $1.63M | ﹤0.01% |
313,300
-238,900
| -43% | -$1.4M |
|
3175
Chesapeake Utilities
CPK
$3.18B
| $1.63M | ﹤0.01% |
17,017
-2,211
| -11% | -$205K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.